Details
Nicerium Uno Indications
Treatment of conditions characterized by the deterioration of cognitive function, states after stroke, vascular dementia (multi-infarct dementia), degenerative conditions associated with dementia (senile and presenile dementia Alzheimer's type, dementia in Parkinson's disease) because the drug has a positive effect not only on the state of cognitive functions but also a violation of mood and behavior - has a positive effect on the level of vitality, concentration and emotional state.
Dosage & Administration
To ensure better absorption of the capsules should be swallowed whole, washed down with a glass of water before meals. Before starting treatment with the drug Nitserium 30 DNA is necessary to exclude the possibility that the patient's complaints are caused by the primary disease that requires specific treatment.
A typical daily dose - 1 capsule per day (30 mg nicergoline). If this dose the desired effect is not achieved, the daily dose may be increased to two capsules (60 mg of nicergoline day).
After the significant improvement of symptoms in many cases may reduce the dose.
Patients with impaired renal function (serum creatinine more than 2 mg / 100 ml), the dose should be reduced.
Since the effect of the drug is increasing gradually, it is recommended to take the drug for a long time. At appropriate times, but not less frequently than every 6 months, it is necessary to assess the need for further treatment of drug Nitserium 30 DNA.
Contradictions
Hypersensitivity to nicergoline, ergot alkaloids other or any of the ingredients of the preparation. Recent myocardial infarction, acute bleeding, severe bradycardia (<50 bpm. / Min), hypotension, orthostatic dysregulation, simultaneous treatment with sympathomimetic stimulating α- or β-receptors. During pregnancy and breastfeeding. Childhood.
